CCX282-B: Clinical Trials

4 trials of CCX282-B, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 1 completed. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Terminated 3, Completed 1

Follow CCX282-B: new trials by email Literature Review of CCX282-B trials Research Report on CCX282-B

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease
GSK1605786A - Crohn's Disease
Phase 3TerminatedGlaxoSmithKline2552011-11-112018-01-29
GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease
GSK1605786A, Placebo - Crohn's Disease
Phase 3TerminatedGlaxoSmithKline2292011-05-092017-09-07
Open-Label Extension Study of GSK1605786A
GSK1605786A - Crohn's Disease
Phase 3TerminatedGlaxoSmithKline3992011-04-012017-09-14
A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease
GSK1605786A, Placebo - Crohn's Disease
Phase 3CompletedGlaxoSmithKline6082010-12-202017-09-19

Conditions studied

Crohn Disease (4)  ·  Inflammatory Bowel Diseases (2)

Sponsors

GlaxoSmithKline (4)

Countries

Australia (4)  ·  Austria (4)  ·  Belgium (4)  ·  Canada (4)  ·  Czechia (4)  ·  Denmark (4)  ·  France (4)  ·  Germany (4)  ·  Hungary (4)  ·  Israel (4)  ·  Italy (4)  ·  Japan (4)  ·  New Zealand (4)  ·  Poland (4)  ·  Slovakia (4)